LEXUS MARTIN: Open Payments
NPI 1265090179 · SULPHUR, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 58 payments from 16 companies in 2025. Trend: 2023 $673 · 2024 $678 · 2025 $1,208
Food & beverage: $1,208
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $213 |
| Medtronic, Inc. | 1 | $149 |
| Novo Nordisk Inc | 9 | $146 |
| Insulet Corporation | 8 | $144 |
| Ascendis Pharma Endocrinology Inc | 6 | $112 |
| Dexcom, Inc. | 4 | $78 |
| Amgen Inc. | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Tandem Diabetes Care, Inc. | 3 | $50 |
| ABBVIE INC. | 3 | $46 |
Products named: MOUNJARO, MINIMED 780G, Omnipod, Ozempic, Yorvipath, Dexcom G6 Transmitter, JARDIANCE, EVENITY.
Industry payments across LA — which companies pay providers there.
